共 32 条
[1]
Siegel RL(2017)Jemal A (2017) Cancer Statistics CA Cancer J Clin 67 7-30
[2]
Miller KD(2017)Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM) Eur J Cancer 75 284-298
[3]
Duffy MJ(2018)Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer J Breast Cancer 21 173-181
[4]
Harbeck N(2019)The prognostic value of the AJCC 8th edition staging system for patients undergoing neoadjuvant chemotherapy for breast cancer Ann Surg Oncol 18 e1347-e1352
[5]
Nap M(2018)Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution Clin Breast Cancer 366 2087-2106
[6]
Kim I(2005)Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 347 1233-1241
[7]
Choi HJ(2002)Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 86 62-67
[8]
Ryu JM(2014)Personalized therapy for breast cancer Clin Genet 12 384-389
[9]
Kantor O(2016)Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of clinical oncology clinical practice guideline summary J Oncol Pract 21 50-57
[10]
Bao J(2012)Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry Breast undefined undefined-undefined